Leading AI-driven Drug Discovery Company Exscientia Expands to The Oxford Science Park

OXFORD, England, November 1, 2018 /PRNewswire/ -- Facilities in The Schrödinger Building to bring together AI experts and biologists In a key point in its growth strategy, Exscientia, the innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery,...

from PR Newswire: //https://ift.tt/2AF8pCE